E/Z-2-Benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one | UVB-induced skin damage (cancer, skin aging) | Cells | 10 volunteers | Tigges et al., 2014 |
6-Methyl-1,3,8-trichlorodibenzofuran (a so-called selective AhR modulator) | Breast cancer, prostate cancer, metastasis, lung cancer | Cells | No | Fritz et al., 2009; Zhang et al., 2012 |
Tranilast | Breast cancer | Cells, animals | No | Prud'homme et al., 2010 |
Leflunomide | Melanoma | Cells | No | |
6,2′,4′-Trimethoxyflavone and GNF351 | Head and neck cancer | Cells | No | DiNatale et al., 2012 |
Sulindac, leflunomide, 4-hydroxytamoxifen, mexiletine, and omeprazole | Cancer, bone preservation | Cells | No | Jin et al., 2012 |
VAF347 | Inflammation, transplant acceptance, IL-22 induction | Cells, animals | | Hauben et al., 2008; Lawrence et al., 2008; Baba et al., 2012 |
Aminoflavone | Breast cancer, renal cancer | | Phase II | Loaiza-Pérez et al., 2004; Callero et al., 2012 |
ITE | Autoimmunity | Animals | No | Yeste et al., 2012 |
FICZ | Irritable bowel disease | Human cells, animals | No | Monteleone et al., 2011 |
Kynurenine inhibitor | Glioblastoma | Human cells | No | Opitz et al., 2011 |
FICZ, kynurenine, and 3,3′-diindolylmethane | NK cell antitumor activity | Cells, animals | No | Shin et al., 2013 |
StemRegenin 1 | Expansion of hematopoietic stem cells | Cells | No | Boitano et al., 2010 |
Coal tar | AD | Skin cultures | | van den Bogaard et al., 2013 |